NIH study finds low-intensity therapy for Burkitt lymphoma is highly effective

NIH study finds low-intensity therapy for Burkitt lymphoma is highly effective

NON-HODGKIN LYMPHOMA - FIND OUT MORE - Non Hodgkin lymphoma is the 5th most common cancer in the UK. Find out about symptoms, causes, diagnosis and treatment from our website: http://www.cancerresearchuk.org/cancer-help/type/non-hodgkins-lymphoma/

NON-HODGKIN LYMPHOMA - FIND OUT MORE - Non Hodgkin lymphoma is the 5th most common cancer in the UK. Find out about symptoms, causes, diagnosis and treatment from our website: http://www.cancerresearchuk.org/cancer-help/type/non-hodgkins-lymphoma/

Burkitt lymphoma  starry sky

Burkitt lymphoma starry sky

IHC for ALL:  Precursor B = Tdt, HLA-DR, 19, 10 (in the t(1;19) and +/- 20.  Burkitt = HLA-DR, 19, 20, sIg, and +/- 10 but TdT negative. Precursor t = TdT, CD7 but DR negative.

IHC for ALL: Precursor B = Tdt, HLA-DR, 19, 10 (in the t(1;19) and +/- 20. Burkitt = HLA-DR, 19, 20, sIg, and +/- 10 but TdT negative. Precursor t = TdT, CD7 but DR negative.

Study shows who survives Burkitt lymphoma

Study shows who survives Burkitt lymphoma

Burkitt's Lymphoma

SMASH: Share and be Aware of Burkitt's Lymphoma

SMASH: Share and be Aware of Burkitt's Lymphoma

Pinterest
Search